Immunopharma Consulting Ltd in Oxted, RH8 0ND

Description

Data updated on: 01-11-2023

Registered with number 06617668 sixteen years ago, Immunopharma Consulting Ltd was set up as a Private Limited Company. The firm's active office address is 20 Westlands Way, Oxted. This company's Standard Industrial Classification Code is 72110: Research and experimental development on biotechnology. Immunopharma Consulting Limited reported its account information for the period up to 2022-08-31. The firm's latest confirmation statement was released on 2023-06-11.

Anne C., James C. and Jonathan C. are listed as company's directors and have been monitoring progress towards achieving the objectives and policies since 2008. In order to find professional help with legal documentation, this limited company has been utilizing the skills of Pamela M. as a secretary for the last sixteen years.

Anne C. is the individual who controls this firm, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-08-31	2012-08-31	2013-08-31	2014-08-31	2015-08-31	2016-08-31	2017-08-31	2018-08-31	2019-08-31	2020-08-31	2021-08-31	2022-08-31	2023-08-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	14 995	9 598	6 799	4 129	1 727	45

Balance Sheet
Cash Bank In Hand	21 771	12 624	9 605	6 821	3 910	3 324
Cash Bank On Hand						3 324	2 790	2 351	6 888	6 869	9 185	97 204	110 933
Current Assets	21 771	13 855	9 605	6 833	3 922	3 336
Debtors		1 231		12	12	12					5 813
Net Assets Liabilities Including Pension Asset Liability	14 995	9 598	6 799	4 129	1 727	45
Other Debtors				12	12	12
Tangible Fixed Assets	500

Capital & Reserves
Called Up Share Capital	100	100	100	100	100	100
Profit Loss Account Reserve	14 895	9 498	6 699	4 029	1 627	-55
Shareholder Funds	14 995	9 598	6 799	4 129	1 727	45

Other Financial Data
Creditors						3 291	4 323	5 369	6 580	7 681	7 118	28 066	32 207
Creditors Due Within One Year Total Current Liabilities	7 276	4 257	2 806	2 704	2 195	3 291
Fixed Assets	500
Fixtures Fittings Tools Equipment	500
Fixtures Fittings Tools Equipment Cost Or Valuation	2 000	2 000
Fixtures Fittings Tools Equipment Depreciation	1 500	2 000
Fixtures Fittings Tools Equipment Depreciation Charge For Period		500
Net Current Assets Liabilities	14 495	9 598	6 799	4 129	1 727	45	-1 533	-3 018	308	-812	7 880	69 138	78 726
Number Shares Allotted							100	100	100	100	100	100	100
Other Creditors Due Within One Year	5 384	4 257	2 806	2 704	2 195	3 291
Par Value Share							1	1	1	1	1	1	1
Prepayments Accrued Income Current Asset		1 231
Tangible Fixed Assets Cost Or Valuation	2 000	0	0	0	0	0
Tangible Fixed Assets Depreciation	1 500	0	0	0	0	0
Tangible Fixed Assets Depreciation Charge For Period		500	0	0	0	0
Taxation Social Security Due Within One Year	1 892
Total Assets Less Current Liabilities	14 995	9 598	6 799	4 129	1 727	45	-1 533	-3 018	308	-812	7 880	69 138	78 726

Company staff

Pamela M.

Role: Secretary

Appointed: 11 June 2008

Latest update: 10 February 2024

Anne C.

Role: Director

Appointed: 11 June 2008

Latest update: 10 February 2024

James C.

Role: Director

Appointed: 11 June 2008

Latest update: 10 February 2024

Jonathan C.

Role: Director

Appointed: 11 June 2008

Latest update: 10 February 2024

People with significant control

Anne C.

Notified on 12 June 2016

Nature of control:

over 3/4 of shares

James C.

Notified on 12 June 2016

Ceased on 31 March 2023

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	31 May 2024
Account last made up date	31 August 2022
Confirmation statement next due date	25 June 2024
Confirmation statement last made up date	11 June 2023

Annual Accounts
Start Date For Period Covered By Report	2016-09-01
End Date For Period Covered By Report	2017-08-31
Annual Accounts
Start Date For Period Covered By Report	2017-09-01
End Date For Period Covered By Report	2018-08-31
Annual Accounts
Start Date For Period Covered By Report	2018-09-01
End Date For Period Covered By Report	2019-08-31
Annual Accounts
Start Date For Period Covered By Report	2019-09-01
End Date For Period Covered By Report	2020-08-31
Annual Accounts
Start Date For Period Covered By Report	2020-09-01
End Date For Period Covered By Report	2021-08-31
Annual Accounts
Start Date For Period Covered By Report	2021-09-01
End Date For Period Covered By Report	2022-08-31
Annual Accounts
Start Date For Period Covered By Report	2022-09-01
End Date For Period Covered By Report	2023-08-31

Immunopharma Consulting Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Pamela M.

Anne C.

James C.

Jonathan C.

People with significant control

Anne C.

James C.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest companies